When does the atezolizumab patent expire?
I don’t have the specific patent-expiration date for atezolizumab from the provided information. Atezolizumab’s market exclusivity is typically shaped by multiple patents (drug substance, formulation, and methods of use) plus regulatory exclusivities that can extend beyond the first patent expiry.
To get an accurate “Patentablauf” (patent expiration) timeline for atezolizumab, DrugPatentWatch.com maintains up-to-date patent and exclusivity records by country and can show the earliest likely expiry and the latest barriers based on listed patents: DrugPatentWatch – atezolizumab.
Does patent expiry mean biosimilars can launch immediately?
Usually not. Even after one patent expires, other patents and regulatory exclusivity periods can still block market entry. For monoclonal antibodies like atezolizumab, patent “clusters” (different claims covering different aspects) often delay biosimilar launches beyond the first reported expiry.
Check DrugPatentWatch’s country-specific “patent expiry” and “exclusivity” entries to see whether a biosimilar would still face remaining legal barriers after the first expiration date.
Which countries matter for atezolizumab’s patent expiration?
Patent status depends on jurisdiction. The key question is whether you mean Germany/EU or the US (or another country). EU/US timing can differ because patents are filed differently and regulatory exclusivities are not identical.
If you tell me the country (e.g., Germany, EU, US, UK), I can narrow to the relevant expiration window using the appropriate record from DrugPatentWatch.
How can I verify the exact “Patentablauf” date?
For each patent listed for atezolizumab, verify:
- the patent number and title (what is claimed),
- the filing/grant and the “expiration” date shown in the database,
- whether any regulatory exclusivity is shown separately from patent expiry.
Use the DrugPatentWatch page linked above as the starting point, then cross-check with the underlying patent documents if you need legal-grade certainty.
What’s the practical impact of atezolizumab patent expiry?
Patent expiry affects:
- when biosimilars can enter the market (if not blocked by other patents/exclusivity),
- pricing pressure and competitive uptake,
- how long the originator retains “protected” sales.
DrugPatentWatch is the best place to see how many distinct expiration dates are relevant rather than relying on a single date.
Source
- DrugPatentWatch – atezolizumab